Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial
Titel:
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial
Auteur:
Lasocki, Sigismond Capdevila, Xavier Vielle, Bruno Bijok, Benjamin Lahlou-Casulli, Maria Collange, Vincent Grillot, Nicolas Danguy des Deserts, Marc Duchalais, Alexis Delannoy, Bertrand Drugeon, Bertrand Bouzat, Pierre David, Jean-Stéphane Rony, Louis Loupec, Thibault Léger, Maxime Rineau, Emmanuel